Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
Tuesday, October 14, 2008 - 03:21
in Health & Medicine
In a randomized controlled trial called the "Evaluate the Clinical use of vitamin K Supplementation in Postmenopausal Women with Osteopenia" (ECKO) trial, Angela Cheung and colleagues at the University of Toronto found that a high dose daily vitamin K1 supplement did not protect against age-related bone mineral density (BMD) decline. However, as reported in this week's PLoS Medicine, the findings also suggest that vitamin K1 may protect against fracture and cancer in postmenopausal women with osteopenia.
Read the whole article on Physorg
More from Physorg
Related
- Vitamin K does not stem BMD decline in postmenopausal women with osteopeniaTue, 14 Oct 2008, 4:21:25 EDT
- Calcium plus vitamin D supplementation is not associated with a reduced breast cancer riskTue, 11 Nov 2008, 16:37:31 EST
- Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trialTue, 30 Dec 2008, 16:21:42 EST
- Vitamin K linked to insulin resistance in older menWed, 26 Nov 2008, 10:23:02 EST
- No protective effect on cancer from long-term vitamin E or vitamin C supplementationSun, 16 Nov 2008, 13:57:08 EST